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GENETIC DISORDERS - DEVELOPMENT
Receptor protein tyrosine kinases in perinatal developing
rat kidney
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Receptor protein tyrosine kinases in perinatal developing rat kidney.
We have identified receptor protein tyrosine kinases (PTKs) that are
expressed and/or activated during kidney development. mRNA from fetal
rat kidneys in late gestation (embryonic day 21), was used to prepare a
eDNA template for polymerase chain reaction amplification with primers
based on conserved regions of PTKs, and products were subcloned and
sequenced. Among 346 clones, we identified epidermal growth factor
receptor (EGF-R), Tie-2, platelet-derived growth factor receptor (PDGF-
R)-a, PDGF-R/3, Flk-1, Flt-4, fibroblast growth factor receptor (FGF-
R)-l, FGF-R3, FGF-R4, Met, and RYKJNbtk-l. PTK expression was
studied by immunoprecipitation and immunoblotting of kidney membrane
proteins with specific antibodies. EGF-R, PDGF-Ra, FOF-RI, FGF-R3,
Met, and in some cases Tie-2 protein expression was greater in fetal
kidneys, as compared with kidneys from 12-week-old adult rats (controls).
Flk-1, PDOF-R13, and FGF-R4 proteins were expressed comparably,
however, Flt-4 was not detected. As a reflection of receptor PTK activity,
we assessed endogenous tyrosine phosphorylation, and in vitro autophos-
phorylation. EGF-R and PDGF-Ra displayed activity in fetal, but not
adult kidneys. FGF-R3 and Flk-1 were active in some fetal kidneys, and
the other PTKs were not active. Thus, in late gcstational rat kidney, there
are distinct patterns of receptor PTK expression and activity. EGF-R,
PDGF-Ro, FGF-R3 and Flk-1 are among the PTK.S that are activated, and
they may mediate perinatal development of renal epithelial, interstitial, or
vascular structures.
Receptor protein tyrosine kinases (PTKs) function as trans-
membrane receptors for peptide growth factors, and contain an
intrinsic tyrosine kinase as a part of their cytoplasmic domains
[1—31. It is believed that binding of a peptide ligand to the
extracellular domain of the corresponding receptor PTK leads to
activation of the PTK, in association with phosphorylation of the
receptor on multiple tyrosine residues ("autophosphorylation"),
and phosphorylation of substrate proteins [1—31. The signal may
then be transmitted to nuclear or cytoplasmic effectors through a
series of "adaptor" molecules, and serine/threonine protein ki-
nases, collectively known as the mitogen activated protein kinase
pathway [2, 3]. Ultimately, signals from PTKs lead to cell prolif-
eration, differentiation, or other responses. Hanks, Quinn and
Hunter [1 proposed that PTKs can be segregated into families,
based on the conservation of amino acid sequences of both their
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catalytic and non-catalytic domains. Despite strong similarities at
the amino acid level, PTK genes have been shown to display
distinct temporal and spatial patterns of expression [5, 6]. Such
specific expression patterns of a receptor PTK and/or its ligand,
and association of a particular PTK with a distinct phenotype
suggest a unique role in cell growth or differentiation during
development, and so far, several receptor PTKs have been
implicated in development [7—19].
Interaction of the ureteric bud with the metanephric mesen-
chyme at embryonic gestational days 11 to 12 (ElI to E12) in the
mouse and rat, or weeks 4 to 5 in humans initiates metanephric
kidney development [20, 21]. Following the initial interaction, the
ureteric bud branches into the mesenchyme. The ureteric bud will
eventually form the collecting system, while its outgrowths will
develop into the collecting ducts of the kidneys. In parallel, the
mesenchymal cells adjacent to the ureteric bud are induced to
aggregate and convert into epithelium, which in later gestation
will proliferate and differentiate into the epithelial component of
tubules and glomeruli. The appearance of endothelial and mes-
angial cells in the developing kidney is stimulated by differentiat-
ing epithelium, although the precise origin of these cells has not
been determined conclusively [22]. Blood vessels form in the
embryonic kidney through either vasculogenesis or angiogenesis
[22]. Unlike humans, the process of nephrogenesis in rats and
mice is not complete until after birth. Thus, late gestational (E21)
kidneys will demonstrate fully or intermediately mature nephrons
in the renal medulla and central cortex, but early stages of
nephrogenesis may also be evident just beneath the renal capsule.
Several growth factor receptor PTKs may participate in meta-
nephrogenesis. At the onset of kidney development, c-ret and c-ros
are expressed by the ureteric bud [13, 23], and kidney develop-
ment is severely impaired in c-ret knockout mice [13]. The PTKs
that mediate postinductive proliferation and differentiation are
less well defined. Organ culture studies have suggested that nerve
growth factor, insulin-like growth factor-i, transforming growth
factor (TGF)-a, and their corresponding receptors, as well as c-ret
and c-ros, may play a role in tuhulogenesis [9, 21, 23, 241. For
example, addition of c-ret or c-ros antisense oligonucleotides to
E13 kidneys in organ culture resulted in a decrease in nephrons,
atrophy of mcsenchymal cells, and a reduction in biosynthesis of
cxtracellular matrix proteins [24]. Platelet-derived growth factor
receptor (PDGF-R)-f3 mediates differentiation of mesangial cells
and the glomerular tuft [14]. Endothelial cell-specific P1'Ks,
including Tie-2, are expressed in the kidney, as well as several
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Fig. 1. Predicted amino acid sequences of PTK domains cloned from fetal rat kidney (E21). The receptor PTK consensus sequence, showing conserved
residues, is presented above. The amino acids highlighted in bold type were used for derivation of PCR primers (Methods).
growth factors with angiogenic potential that act via receptor
PTKs [22].
We have previously demonstrated that fetal rat kidneys in late
stages of gestation (E16 to E21) contain multiple proteins that are
endogenously tyrosine phosphosylated, including the epidermal
growth factor receptor (EGF-R) [25]. Expression of EGF-R is
enhanced in E16 to E21 rat kidneys (4- to 10-fold above adult
control values), and there is endogenous activation of EGF-R
tyrosine kinase and substrates [25, 26]. Other studies have shown
that the addition of EGF to kidneys in organ culture stimulates
DNA synthesis, cell growth and nephron differentiation [27].
Embryonic kidneys in organ culture produce TGF-cs (a ligand for
EGF-R), and anti-TGF-a antibody inhibits tubulogenesis in vitro
[28]. Some strains of EGF-R knockout mice show developmental
abnormalities in collecting duct epithelium and develop renal
failure [18]. Together, these results provide support for EGF-R as
a mediator of nephrogenesis. Furthermore, during kidney devel-
opment, EGF-R signalling may be determined principally by the
level of EGF-R expression and activation, rather than by ligand
availability [25, 26].
Since the fetal rat kidney in late gestation contained multiple
tyrosine phosphoproteins besides EGF-R [25], it was reasonable
to propose that at least some of these other phosphoproteins may
represent additional activated PTKs that may be involved in
kidney development. By analogy to EGF-R, expression of other
PTKs relevant to nephrogenesis may be increased in the fetal
kidney. The purpose of the present study was to identify other
receptor PTKs that are expressed and activated during kidney
development. Using a polymerase chain reaction (PCR)-based
approach, we cloned 11 receptor PTK-related cDNA sequences in
E21 rat fetal kidney. In the majority of cases, the corresponding
PTK proteins were expressed in the fetal kidney, and some
displayed tyrosine phosphorylation, supporting a role for these
PTKs in kidney development.
METHODS
Materials
Male and pregnant female Sprague-Dawley rats were pur-
chased from Charles River Canada (St. Constant, Quebec, Can-
ada). PCR and restriction enzymes were from Gibco Laboratories
(Burlington, Ontario, Canada) and New England Biolabs (Mis-
sissauga, Ontario, Canada). DNA sequencing kits were from
Pharmacia Biotech (Baie Urfe, Quebec, Canada). Electrophoresis
and immunoblotting reagents were from Biorad Laboratories
(Mississauga, Ontario, Canada), and Amersham Canada
(Oakviile, Ontario, Canada). Rabbit antibodies to receptor PTKs
(except EGF-R) were purchased from Santa Cruz Biotechnology
(Santa Cruz, San Diego, CA, USA). Rabbit antiserum to EGF-R,
RK-2 [25], was kindly provided by Drs. B. Margolis and J.
Schlessinger (New York University, New York, NY, USA). Anti-
phosphotyrosine monoclonal antibody, PY2O, was from Transduc-
tion Laboratories (Lexington, KY, USA).
PCR cloning of PTK-related sequences
To prepare the cDNA template for PCR amplification, total
RNA was isolated from fetal rat kidneys (E21), using Trizol
reagent (Gibco Laboratories), according to the manufacturer's
instructions. The RNA was then enriched for poly A RNA, using
PolyATract (Promega, Madison, WI, USA). Conserved regions
in catalytic domains of PTKs were used to derive degenerate
oligonucleotide primers for PCR [5, 29]. First strand eDNA was
synthesized using 1 g of poly A RNA, reverse transcriptase,
and reverse primer-i (5'-GGAATTCCAAAGGACCAGACG-
TC-3'), which corresponds to the PTK amino acid sequence
DVWSFG (Fig. 1). Forward primer-i (5'-CGGATCCAC[A!
C]GNGA[CIT][C/T]T-3'; N represents four nucleotides), which
corresponds to the PTK amino acid sequence IHRDL (Fig. 1),
was added to the first strand cDNA, and the eDNA was amplified
by PCR (40 cycles). The PCR cycle was 1.5 minutes at 95°C
(denaturation), two minutes at 37°C (annealing), and three min-
utes at 65°C (elongation). One tenth of the first reaction was then
re-amplified (35 cycles) with a second set of "nested" primers, that
is, forward primer-2 (5 '-GGGTCTAGATCGACGA[T/C]CT-
NGCNGCN[A/G]CNAA-3'), and reverse primer-2 (5'-GG-
GAGCTCGGTACC[CIT]TC[A!C/G]GGNGCCATCAC-3'),
corresponding to the PTK amino acid sequences DLAARN and
WMAPE, respectively (Fig. 1). Reverse primer-2 is designed to
exclude cytoplasmic PTKs, and select for growth factor receptor
PTKs, since the latter generally have a methionine as part of the
WMAPE consensus sequence, while cytoplasmic PTKs have a
threoninc [29]. The second PCR cycle was one minute at 94°C
(denaturation), one minute at 45°C (annealing), and two minutes
at 65°C (elongation). After size-fractionation on agarose gels,
appropriately-sized products (—180 bp) were cut out, extracted,
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Consensus XHRDLAARNVLV VKI-DFGLARDI Y G----LP-KWMAPES YT--SDVWSFGV
EGF-R
FGF-R1
FGF-R3
FGF-R4
FIk-1
FIt-4
Met
PDGF-Ra
PDGF-R3
RYKJNbtk-1
Tie-2
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Table 1. Summary of PTK clones
PTK
family PTK
Fully
sequenced
Partially Restriction
sequenced° digestisequencing' Total
EGF-R EGF-R 3 3 10 16
Tic/Tek Tie-2 1 0 10 11
PDGF-R PDGF-Ra
PDOF-Rf3
Flk-1
Flt-4
1
1
6
2
0
0
19
0
8
9
70C
5
9
10
95
7
FGF-R FGF-R1
FGF-R3
FGF-R4
12
0
1
37
0
0
119d1
7
13
168
7
14
Mct Met 1 0 2 3
Other RYK/Nbtk-1 0 0 I 1
Total 87 254 341
C Partially sequenced: single base sequencing.
' FGF-R1 and Flk-1 clones were identified by rcstriction digestion;
other clones were fully sequenced
C Clones containing both SmaI and BglII sites are regarded as Flk-1
d Clones containing both BspHI and Noel sites are regarded as FGF-R1
and ligated into the TA-cloning plasmid vector pCR II (Invitro-
gen, San Diego, CA, USA). Following transformation into com-
petent E. coli, plasmid DNA was prepared using a kit (Qiagen,
Chatsworth, CA, USA). Nucleotide sequences of plasmid DNAs
isolated from transformants were determined using double-
stranded dideoxy sequencing. Nucleotide sequences of clones
were analyzed and compared to sequences of known PTKs using
the Basic Local Alignment Search Tool (BLAST; Blastn program;
National Center for Biotechnology Information, National Insti-
tutes of Health, Bethesda, MD, USA). Initially, clones were fully
sequenced; subsequently, clones were examined by comparison of
single base sequencing reactions, and novel clones were fully
sequenced. Based on the sequencing results of the first 87 clones,
the second set of clones was first restriction-digested (with
appropriate restriction enzymes; see below) to eliminate fibroblast
growth factor receptor (FGF-R)-1 and Flk-1 clones prior to
additional sequencing (Table 1).
Immunoprecipitation and immunoblotting of PTKs
Kidneys were dissected from fetal rats at E21, or from 12-week-
old adult male rats (control). Kidneys were then pooled and
microsomal membrane fractions were prepared as described
earlier [25]. The recovery and distribution of proteins in mem-
brane preparations has been described previously, and it should
be noted that there were no significant differences in these
parameters between fetal and adult kidneys [25]. Membrane
fractions of other adult organs were prepared by an analogous
protocol.
Membrane proteins (0.7 mg) were soluhilized, and were then
immunoprecipitated with primary rabbit antisera directed to
specific PTKs (or nonimmune sera in controls), as described
previously [25]. In some experiments, in vitro phosphorylation of
kidney membrane proteins was first carried out at 22°C for 20
minutes in buffer containing 50 mtvi Hepes, pH 7.4, 10 mM MgCI2,
10 mM MnCI2, 25 tLM ATP, and protease and phosphatase
inhibitors, as described previously [25]. After immunoprecipita-
tion, immune complexes were incubated with agarose-coupled
protein A, boiled in Laemmli sample buffer, and subjected to
SDS-PAGE under reducing conditions. Proteins were then dcc-
trophoretically transferred onto nitrocellulose paper, blocked
with 3% BSA/2% ovalbumin, and incubated with antibodies to
specific PTKs or to phosphotyrosine. Blots were developed using
alkaline phosphatase or horseradish peroxidase-conjugated sec-
ondary antibodies and colorimetric or enhanced chemilumines-
cence detection [25].
RESULTS
Cloning of PTK domains
Three highly conserved regions of the catalytic domains of
receptor PTKs were used to derive oligonucleotide primers for
PCR amplification of PTK-related sequences in E21 rat kidney
(Fig. 1). The remaining amino acid sequences of known PTKs in
this region, while broadly conserved, are sufficiently diverse to
permit the designation of any candidate PTK clones as previously
identified or novel. The first round of reverse transcriptase PCR
did not yield a detectable product, probably reflecting low levels of
PTK mRNAs. Re-amplification of the first reaction (Methods)
resulted in a —180 bp product, which was subcloned. A total of
346 clones were analyzed by DNA sequencing or restriction
enzyme digestion. Among the first 87 clones, 28 were sequenced
fully and 59 were identified on the basis of partial DNA sequenc-
ing (Table 1). The predicted amino acid sequences of the PCR
products are presented in Figure 1. Our earlier studies demon-
strated EGF-R protein expression in fetal kidney [25]. Thus, as
expected, EGF-R eDNA [6] was found among the PTK clones.
Among the other eDNA sequences, the large majority were
FGF-R1 [30] and Flk-1 [31], a receptor for vascular endothelial
cell growth factor (Table 1). Additional clones included Tie-2 (an
endothelial-specific receptor PTK also known as Tek), PDGF-Ra,
PDGF-Rf3, Flt-4 (Flk-1-like PTK), FGF-R4, and Met (hepatocyte
growth factor receptor; Table 1) [6, 17, 29, 32].
Prior to the second round of sequencing, we analyzed restric-
tion enzyme sites within the regions flanked by the nested PCR
primers in the PTK PCR products shown in Table 1, as well as in
corresponding eDNA sequences of 135 other PTKs (from DNA
databases). The eDNA sequence of the FGF-R1 PCR product
contains both BspHI and Nael sites, while the Flk-1 product
contains both Smal and BglII sites. Thus, subsequent analysis of
PTK clones first involved digestion of plasmid DNA with either
BspHT and NaeI, or Smal and BglTT restriction enzymes. This
protocol identified an additional 119 FGF-R1 and 70 FIk-l clones
(Table 1). Four of these clones were fully sequenced to verify that
they actually represented FGF-Rl or Flk-l. Moreover, examina-
tion of DNA sequences of all other PTKs showed that these other
PTKs do not contain either of the two combinations of restriction
sites. Consequently, we believe that there is a low probability of
having inadvertently eliminated novel PTKs from full DNA
sequencing by using the restriction-digestion approach. Full se-
quencing of another 65 clones yielded two PTKS that had not been
identified in the first round (Table 1). The first was FGF-R3 [19];
the second sequence was compatible with RYK (an atypical PTK
expressed in multiple tissues) [29], or with Nbtk-1 (a partially-
sequenced molecule expressed in multiple tissues and tumors)
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Fig. 2. Expression and tyrosine
phosphorylation of EGF-R (Mr 170k), PDGF-
Rx (180k), FGF-R3 (120k), and Flk-1 (205k).
For each PTK, the upper pane! demonstrates
protein expression and the lower panel shows
endogenous tyrosine phosphorylation and in
vitro autophosphorylation. In each lower panel,
membranes were preincubated with ATP (+, in
vitro tyrosine autophosphorylation assay) or
were untreated (endogenous tyrosine
phosphorylation). EGF-R and PDGF-Ra: The
lower band in the upper panels probably
represents a degradation product. Abbreviations
are: FK, fetal kidney; AK, adult kidney; All,
adult heart; ALi, adult liver; ALu, adult lung;
IP, immunoprecipitation; P-tyr,
phosphotyrosine.
[33], In addition, according to our method we cloned five PCR
products that did not appear to be PTKs (not shown).
PTK expression and activation
Expression and activation of cloned receptor PTKs was studied
using membrane fractions from E21 fetal rat kidneys. Preliminary
studies demonstrated that direct immunoblotting of kidney mem-
brane proteins with PTK-specific antibodies was not sufficiently
sensitive to detect PTK proteins. Therefore, it was necessary to
first immunoprecipitate kidney membrane proteins with specific
antibodies, and then to immunoblot the immunoprecipitates with
the immunoprecipitating antibody. The same protocol was carried
out using kidney membranes from 12-week-old adult (control)
rats, as well as membranes of other adult rat tissues for compar-
ison. To determine if expressed PTKs were active during kidney
development, we assessed endogenous tyrosine phosphorylation
of immunoprecipitated PTKs in fetal and adult (control) kidney
membranes by immunoblotting with anti-phosphotyrosine anti-
body (without preincubation with ATP). We also measured
tyrosine autophosphorylation in vitro (that is, incubation of kidney
membranes with exogenous ATP, prior to immunoprecipitation
with specific antibodies and immunoblotting with anti-phospho-
tyrosine antibody). The presence of endogenous tyrosine phos-
phorylation or in vitro autophosphorylation is a reflection of
receptor PTK activity (Discussion). The results are presented in
Figures 2 and 3, and are summarized in Table 2.
The first group includes PTKS that were activated in fetal
kidney (Fig. 2). In keeping with prior results, EGF-R protein
EGF-R PDGF-Rcx
FK AK AK ALi ALu
170k -. iJ
IP: anti-EGF-R
Blot: anti-EGF-R
FK AK FK AK
'1—
AlP + +
IP: anti-EGF-R
Blot: anti-P-tyr
FK AK FK AK
180k -.
ATP
EK AK AH ALl ALu
IP: anti-POGE-Ra
Blot: anti-PDGF-Rcx
EK AK FK AK
lP: anti-PDGF-Ra
Blot: anti-P-tyr
120k -.
FGF-R3
FK AK AH ALl ALu
IP: anti-EGF-R3
Blot: anti-FGF-R3
FK AK FK AK
)
205 k
205k -.
Flk-1
FK AK ALu
IP: anti-Elk-i
Blot: anti-Ak-i
EK AK FK AK
120k
ATP + + ATP + +
IP: anti-FGF-R3
Blot: anti-P-tyr
IP: anti-Ak-i
Blot: anti-P-tyr
180k —
170k -.
+ +
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Fig. 3. Protein expression of FGF.R1 (155k,
150k, and 125k), Met (145k), Tie-2 (150k),
FGF-R4 (95k), and PDGF.Rp (180k). FGF-R1:
Three specific bands are present; the uppermost
band is nonspecific. Met: The upper band
probably represents the unprocessed Met
precursor. Tie-2: The upper and lower panels
represent two different patterns of Tie-2 protein
expression in adult kidneys. PDGF-R13: The
bands above and below the 180k band, present
in the four lanes, are nonspecific. Abbreviation
is: IP Ab+, immunoprecipitation with specific
antibody; the control immunoprecipitations in
the first two lanes were performed using
nonimniune IgG.
Table 2. Expression and activation of PTKs in kidney
Protein
Tyrosine kinase activity
Endogenous
PTK expression phosphorylation Autophosphorylation
EGF-R Fetal > Adult Fetal Fetal
PDGF-Ra Fetal > Adult ND Fetal
FGF-R3 Fetal > Adult Fetal Fetal
Flk-1 Fetal Adult Fetal Fetal
FGF-R1 Fetal > Adult ND ND
Met Fetal > Adult ND ND
Tie-2 Fetal  Adult ND ND
PDGF-R/3 Fetal Adult ND ND
FGF-R4 Fetal Adult ND ND
Flt-4 ND ND ND
Abbreviation and symbol are: ND, not detected; phosphoiylation
was not found in all membrane preparations from fetal kidneys.
showed high expression in fetal kidneys, in contrast to adult
control kidneys. For comparison, the greatest expression was
found in adult liver (Fig. 2). EGF-R also showed endogenous
tyrosine phosphorylation and marked in vitro autophosphoryla-
tion in fetal kidneys (Fig. 2). PDGF-Ra was highly expressed in
fetal kidneys, and was either expressed weakly or was not detect-
able in other tissues (Fig. 2). PDGF-Ra demonstrated prominent
in vitro autophosphorylation in fetal kidneys (Fig. 2). There was
greater expression of FGF-R3 in fetal kidney, as compared with
adult kidney, although expression was weak, as compared with
adult liver (Fig. 2). FGF-R3 demonstrated endogenous phosphor-
ylation and in vitro autophosphorylation in fetal kidneys, however,
phosphorylation was not detected in all membrane preparations
from fetal kidneys (Fig. 2). Expression of Flk-1 was comparable in
fetal and adult kidneys, and was weak, as compared with adult
lung (Fig. 2). However, Flk-1 demonstrated endogenous phos-
phoiylation and in vitro autophosphorylation in fetal kidneys,
although this phosphorylation was not found in all membrane
preparations from fetal kidneys (Fig. 2).
The second group of PTKS did not display kinase activity (Fig.
3). There appeared to be three isoforms of FGF-R1 expressed in
fetal kidneys, and the three isoforms were expressed at levels
greater than in other tissues examined (Fig. 3). Similarly, Met
showed high expression in fetal kidneys, as compared with adult
kidneys and other adult tissues (Fig. 3). Expression of Tie-2 was
greatest in adult lung, however, there was also substantial expres-
sion in fetal kidneys (Fig. 3). The expression in adult kidneys was
variable among experiments: in some adult kidneys, Tie-2 was
expressed at levels similar to fetal kidneys (Fig. 3, Tie-2, bottom
panel), whereas in others, the expression was lower in adult
FGF-R1 Met
EK AK AH ALu ALl FK AK AH ALl ALu
155k
150k
125k /
IP: anti-FGF-R1
Blot: anti-FGF-R1
145k
-.5
IP: anti-Met
Blot: anti-Met
FGF-R4
a-a..
Tie-2
FK AK AH ALi ALu
FK AK AH ALl ALu
150k-. — S 95k-'-
IP: ariti-FGF-R4
Blot: anti-FGF-R4
150 k-.
IP: anti-Tie-2
Blot: anti-Tie-2
PDGF-RJ3
EK AK FK AK
180 k—s :
P Ab + +
IP: anti-PDGF-R
Blot: anti-PDGF-R13
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kidneys (Fig. 3, Tie-2, top panel). PDGF-RJ3 was expressed
weakly and at comparable levels in fetal and adult kidneys (Fig. 3).
PDGF-R13 was not detected in the other adult tissues, although
we did demonstrate expression of this receptor in cultured
mesangial cells (not shown). FGF-R4 also appeared to be ex-
pressed weakly in fetal and adult kidneys (Fig. 3), and was not
detected reliably in other tissues. However, the anti-FGF-R4
antibody was directed at the human carboxy-terminal amino acid
sequence, and since the analogous rat sequence contains several
discrepant amino acids, the reactivity of this antibody with rat
FGF-R4 may have been suboptimal. Flt-4 was not detected in
fetal or adult kidney, however, there was weak expression in
spleen (not shown), indicating that the anti-Flt-4 antibody was
able to identify Flt-4 in rat tissue. Although FGF-R1, Met, and
Tie-2 proteins were expressed abundantly in fetal kidneys, these
PTKs did not demonstrate any endogenous tyrosine phosphoty-
lation nor in vitro autophosphorylation in fetal and in adult
kidneys (not shown). Similarly, PDGF-Rp, FGF-R4, and Flt-4 did
not demonstrate endogenous phosphorylation nor autophosphor-
ylation (not shown).
Expression of RYKJNbtk-l was not studied at this time, since it
will first be necessary to identify the PTK that corresponds to this
cDNA sequence precisely. Furthermore, while the RYK amino
acid sequence manifests several characteristics of a PTK, the
protein apears to have an unusual ATP binding site, and may not
have tyrosine kinase activity [29].
DISCUSSION
This study demonstrates that in the late gestational rat kidney,
there are distinct patterns of receptor PTK expression and kinase
activity. The initial step in determining which PTKs are present in
fetal kidney was to examine the expression of PTK mRNAs by
using a PCR-based approach [5, 29]. Based on the analysis of 346
cDNA clones resulting from two rounds of PCR, 11 different
receptor PTK-related sequences were found in fetal kidney, and
all sequences corresponded to known PTKs (Table 1). The 11
receptor PTKs originated from five distinct families (Table 1), but
we did not identify any PTK-related sequences of the Axi, Trk,
Ros, insulin receptor and Eph family [35]. RYKINbtk-1 is not a
member of any PTK family, since its sequence is not closely
related to that of any other PTK [35]. Among the 346 clones, there
were only five that appeared to represent unrelated sequences,
indicating that our method was highly specific for PTKs. The PCR
primers, derived from conserved regions of PTK catalytic do-
mains, while degenerate, nevertheless favored amplification of
certain receptor PTK sequences, including FGF-R1 and Flk-1.
Conversely, the design of the PCR primers would tend to exclude
the Eph and AxI family of receptor PTKs, in addition to cytoplas-
mic PTKs, since these PTKS generally do not have a methionine
as part of the WMAPE consensus sequence (Fig. 1) [29, 35]. The
PCR reaction conditions may also have been unfavorable for
amplification of some receptor PTKs, even though the primers
were compatible with the conserved nucleotide sequences of
prototype PTKs in most families. Thus, failure to clone additional
receptor PTKs does not exclude the presence of other receptor
PTKs in E21 rat kidneys. However, it should be noted that when
the same method was used to clone PTKs in other tissues, it
resulted in the identification of PTK-mRNAs that were not found
in E2i kidneys, such as FGF-R2 and insulin-like growth factor
receptor-i [29]. On the other hand, using only one round of
degenerative oligonucleotide-based PCR cloning, Holzman, Mer-
ritt and Fan [34] identified a limited number of receptor PTKs in
E13.5 and E17.5 mouse kidneys, but also several non-receptor
PTKs, as well as a serine/threonine protein kinase.
Nine of the ii cloned PTK-related cDNAs were associated with
expression of corresponding proteins in fetal kidney (Table 2); the
Flt-4 protein may also have been expressed, but below the level of
detectability. The number of clones of each individual PTK eDNA
(Table 1) did not correlate with protein expression, such as Flk-1
clones occurred frequently but Flk-1 protein expression was
relatively weak in fetal kidney, whereas the opposite relationship
was evident with Met (Figs. 2 and 3). Several PTKs showed
enhanced protein expression in fetal kidneys, as compared with
adult (control) kidneys, or with other adult tissues, but increased
protein expression did not invariably correlate with endogenous
tyrosine phosphorylation or in vitro autophosphorylation of PTKs,
both of which reflect kinase activation [1, 2]. It should be noted
that the majority of studies correlating tyrosine kinase activation
with tyrosine phosphorylation of receptors or substrate proteins
are based on acute incubations of cultured cells with growth
factors. However, chronic exposure of cells to growth factors
(which is more analogous to PTK activation in fetal kidney in vivo)
has been shown to induce sustained increases in tyrosine phos-
phorylation of receptors or substrates [36—38]. Thus, EGF-R and
PDGF-Ra revealed significantly enhanced expression in fetal
kidneys, as compared with adult controls, and demonstrated
tyrosine phosphorylation (Fig. 2), implying that EGF-R and
PDGF-Rcs were chronically activated and that these receptors
may be functionally important in kidney development. EGF-R
and PDGF-Ra were most likely phosphorylated by one of their
corresponding ligands, although transactivation by other recep-
tors (such as via heterodimerization) is also a possibility [2].
Chronic activation of receptor PTKs may lead to down-regulation.
Consequently, the quantity of EGF-R and PDGF-Ra protein
demonstrated in fetal kidneys may reflect a down-regulated
amount of receptor protein.
The localization of EGF-R has been reported in the developing
human kidney [39]. Immunohistochemical analysis of 13 week—
old human fetal kidney demonstrated EGF-R in mesenchymal
blastema, immature glomeruli, and tubules [39]. In adult rabbits,
specific '251-EGF binding (reflecting presence of EGF-R) was
demonstrated in almost all segments of microdisseeted tubules,
and in glomeruli [40], while in normal adult human kidney,
EGF-R protein has been localized by immunohistochemistry
mainly to epithelial cells in the thick ascending limb and distal
convoluted tubule, as well as glomerular endothelium and inter-
stitial vascular tree [41]. Thus, in E21 rat kidney, EGF-R is most
likely expressed in developing tubular epithelial or glomerular
cells, and possibly vessels, and EGF-R may mediate proliferation
or differentiation of these cells. PDGF-Ra is generally regarded
as a non-epithelial cell receptor PTK, and PDGF-R mRNA has
been demonstrated in the mesenchymal component of E14.5
mouse kidneys [Fl]. A recent report in human fetal kidneys
(E54 to E81) indicates that PDGF-Ra mRNA and protein is
present mainly in adventitial fibroblasts in the renal intersti-
tium, and in mesangial and vascular cells of early glomeruli
[42]. Thus, PDGF-Rn may mediate development of the renal
interstitial compartment and connective tissue, however; ex-
pression in developing epithelium of mesenchymal origin
should also be considered. Further studies and development of
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suitable reagents will be required to localize these PTKs in the
developing rat kidney.
FGF-R3 and Flk-1 were also tyrosine phosphorylated in fetal
kidneys. FGF-R3 protein expression was greater in fetal kidneys,
as compared with adult controls, while Flk-1 expression was
comparable. However, expression of both FGF-R3 and Flk-1 was
exceptionally weak, as compared with adult liver or lung, respec-
tively (Fig. 2), although these receptors may have been down-
regulated in fetal kidneys due to chronic activation (similar to
EGF-R and PDGF-Ra). Tyrosine phosphorylation of FGF-R3
and Flk-1 was not evident in all preparations of fetal kidneys,
implying either variability between animals, or technical difficulty
in detecting phosphotyrosine due to relatively low levels of PTK
expression in fetal kidney. While our results indicate that FGF-R3
is active in fetal kidney, the localization of FGF-R3 and the
potential role of this receptor in kidney development requires
further study (see below). Flk-l is one of two known receptors for
vascular endothelial growth factor, an endothelial-specific PTK,
which is essential for vasculogenesis [16]. Punctate foci of Flk-1
mRNA have been demonstrated in E12 mouse kidneys [31], and
in glomeruli and medullaiy regions of 17- to 20-week-old human
fetal kidneys [32]. Together with our study, these results suggest a
role for Flk-1 in the development of the renal vasculature. We did
not find mRNA for Flt-1 (the other receptor for vascular endo-
thelial growth factor) in fetal kidney.
Met and FGF-R1 were both highly-expressed in fetal kidneys,
but were not tyrosine phosphorylated (Fig. 3). FGF-R1 appeared
to be expressed as two and three extracellular immunoglobulin-
like domain isoforms of 125 k and 150 to 155 k, respectively, with
the larger isoform possibly involving variable post-translational
processing. This result is consistent with the previous demonstra-
tion of mRNA for both FGF-R1 isoforms in fetal rat kidney [30].
By analogy to Met and FGF-R1, there was no detectable tyrosine
phosphorylation of Tie-2, although protein expression was prom-
inent and appeared to be up-regulated in some fetal kidneys, as
compared with adult (Fig. 3). Previous studies have demonstrated
Met mRNA expression in the E17 kidney, in epithelial cells of
developing nephrons, principally at the tips of ureteric buds [43].
Met can also be expressed in endothelial cells, but it is not known
if Met is expressed by these cells in fetal kidney. Tie-2 appears to
be an endothelial-specific PTK involved in angiogenesis [17]. Its
localization in the developing kidney is presently unknown.
FGF-R1 mRNA has been previously demonstrated in mesenchy-
mal condensations of E12.5 mouse kidneys, and in mesenchymal
elements of the cortex in E14.5 to E17 mouse or rat kidneys
[44—46]. In one study, FGF-R1 mRNA was also found in devel-
oping tubules and Bowman's capsule epithelium [46]. In the
present study, failure to observe tyrosine phosphorylation of Met,
FGF-R1 and Tie-2 despite ample expression suggests these PTKs
may not be functionally active in the late gestational rat kidney
(E21). Alternatively, low levels of PTK activity may have been
present in vivo, or only a small portion of these molecules were
activated, and as a result tyrosine phosphorylation was below the
level of detectability. Another possibility is that Met, FGF-R1 and
Tie-2 had been activated earlier during kidney development (that
is, up to —E17), but that by E21 their activity diminished, and
their expression was in the process of declining towards adult
levels. Finally, PDGF-Rf3, FGF-R4 and Flt-4 did not reveal
detectable tyrosine phosphorylation, and were expressed weakly
in fetal and adult kidneys, or were below the level of detectability.
Thus, it is uncertain to what extent these PTKs are involved in
renal development at E21.
The use of knockout mice has defined critical functional roles
for Ret and PDGF-R13 in kidney development. In El I normal
mouse embryos, c-ret is expressed by the epithelial cells of the
ureteric bud. In c-ret null mice, there is failure of branching of the
ureteric bud, and induction of the metanephric mesenchyme does
not take place, the result being that there is agenesis or severe
dysgenesis of the kidneys [13]. Several recent studies have dem-
onstrated that Ret constitutes part of a multicomponent receptor
for glial cell-derived neurotrophic factor (GDNF), and the phe-
notype of GDNF knockout mice is similar to the Ret knockout
[47]. PDGF-RJ3 null mice show failure of mesangial cell differen-
tiation and proper formation of the glomerular tuft at E16 to E18
[14]. In addition, PDGF-R13 is expressed in differentiating mes-
angial cells of human fetal kidneys, and prior to that is localized in
undifferentiated metanephric mesenchyme [48]. In the present
study, which focused on the developing kidney at E21, we were
unable to clone c-ret, and although PDGF-R/3 clones were
present, PDGF-R13 protein expression was weak. Since PDGF-R13
expression in late gestation appears to be restricted principally to
glomeruli, which constitute only a small portion of the renal
parenchyma, expression of PDGF-Rf3 protein and tyrosine phos-
phorylation may have been below the threshold of detectability.
Regarding the functional role of PTKs in late stages of kidney
development, certain strains of mice with null mutations of
EGF-R show abnormalities of collecting duct epithelium, as well
as renal failure [18], thereby suggesting an important role for
EGF-R in the differentiation of structures derived from the
ureteric bud. Our results, which demonstrate that EGF-R expres-
sion is enhanced and EGF-R tyrosine kinase is activated in E21
kidneys, are in keeping with an important role for EGF-R
demonstrated by use of EGF-R null mice. However, the use of
knockout or mutant mice has been less informative in defining the
role of other PTKs during kidney development. Knockout mice
for FGF-R1, Flk-l and Tie-2 [15—17], as well as a mouse strain
with a chromosomal deletion involving PDGF-Ra [10, 11], gen-
erally show lethal phenotypes, and are not useful in studying
kidney development. FGF-R3 knockout mice reveal abnormal
bone development, but show no apparent kidney abnormalities
[19]. While our study demonstrates that FGF-R3 was tyrosine
phosphorylated and suggests a functional role for this PTK, it is
possible that other growth factor receptor PTKs may compensate
for the absence of FGF-R3 in the null mice. It should also be
noted that mice null for hepatocyte growth factor (the ligand for
Met) show no apparent kidney abnormalities at E16 [49]. Finally,
mice with mutations in FGF-R4 and Flt-4 are presently not
available. Thus, while the results of the present study provide
information on PTK expression and activation in fetal kidney,
development of suitable specific inhibitors, or techniques, such as
organ-specific gene inactivation or inhibition, will be necessary to
conclusively demonstrate or exclude functional roles for the
various PTKS.
Nearly 20% of childhood diseases and approximately 10% of
adult diseases that lead to end-stage renal failure are due to
primary developmental disorders of the kidney. It is important to
understand the role of PTKS in kidney development, as failure of
PTK expression or activation may be associated with renal
dysplasia. Furthermore, the process by which renal tubules re-
cover from acute ischemic injury is believed to recapitulate the
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various steps of the developing nephron [50]. Consequently,
understanding the role of PTKs in kidney development may also
provide insights into the pathogenesis of renal tubular regenera-
tion. By increasing our appreciation of the potential mechanisms
of renal cell growth and differentiation, the results of this and
other studies may eventually lead to improved strategies for
therapies of renal dysplasia or injury.
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